Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chandler

Showing results (471-480 of 482) with videos related to

Pageof 49
Sort By:
Neurosurgery|October 17, 2023
Surgical Outcome of Patients With Supratentorial Meningiomas Aged 80 Years or Older-Retrospective International Multicenter StudyChristoph Schwartz, Ilari Rautalin, Jürgen Grauvogel, et al.
The Journal of Craniofacial Surgery|February 24, 2025
Multidisciplinary Surgical Teams for Cranioplasty: Indications and Outcomes at a Single InstitutionEthan J Houskamp, Chirag Goel, Khizar R Nandoliya, et al.
The New England Journal of Medicine|December 24, 2010
NFKBIA deletion in glioblastomasMarkus Bredel, Denise M Scholtens, Ajay K Yadav, et al.
Journal of Neuro-Oncology|September 4, 2024
Frailty indices predict mortality, complications and functional improvements in supratentorial meningioma patients over 80 years of ageChristoph Schwartz, Moritz F Ueberschaer, Ilari Rautalin, et al.
The Lancet. Oncology|July 2, 2021
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trialJawad Fares, Atique U Ahmed, Ilya V Ulasov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Neuro-Oncology|January 26, 2026
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneityVictor A Arrieta, J Kada Benotmane, Rebecca Du, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Nature Communications|February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathwaysMark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Pageof 49

Showing results (471-480 of 482) with videos related to

Sort By:
Pageof 49
Neurosurgery|October 17, 2023
Surgical Outcome of Patients With Supratentorial Meningiomas Aged 80 Years or Older-Retrospective International Multicenter StudyChristoph Schwartz, Ilari Rautalin, Jürgen Grauvogel, et al.
The Journal of Craniofacial Surgery|February 24, 2025
Multidisciplinary Surgical Teams for Cranioplasty: Indications and Outcomes at a Single InstitutionEthan J Houskamp, Chirag Goel, Khizar R Nandoliya, et al.
The New England Journal of Medicine|December 24, 2010
NFKBIA deletion in glioblastomasMarkus Bredel, Denise M Scholtens, Ajay K Yadav, et al.
Journal of Neuro-Oncology|September 4, 2024
Frailty indices predict mortality, complications and functional improvements in supratentorial meningioma patients over 80 years of ageChristoph Schwartz, Moritz F Ueberschaer, Ilari Rautalin, et al.
The Lancet. Oncology|July 2, 2021
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trialJawad Fares, Atique U Ahmed, Ilya V Ulasov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Neuro-Oncology|January 26, 2026
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneityVictor A Arrieta, J Kada Benotmane, Rebecca Du, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Nature Communications|February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathwaysMark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Pageof 49